ArticleBMC cancer2022

Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.

Yuanyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.